-
Most Popular
Healthcare Stocks
Healthcare encompasses a wide range of organized services to prevent, treat, and diagnose medical needs and mental illnesses. The $336 billion market is expected to grow at a compound annual growth rate of 8% until 2030, demonstrating the necessity of adequate healthcare. Healthcare companies, ranging from retailer CVS to insurance giant UnitedHealth, provide these services to a massive customer base.
7 Recession-Resistant Stocks to Hold Onto for Dear Life in 2024
These seven recession-resistant stocks offer stability and potential growth even in challenging economic conditions.
7 Dependable Dividend Stocks for Long-Term Income
Explore the best dividend stocks for long-term income excelling in the healthcare, retail, tobacco and home improvement markets.
3 Pharmaceutical Stocks That Can Surge Higher Even if The Markets Correct
These are the pharmaceutical stocks to buy as they represent undervalued companies with a deep clinical pipeline that will support growth.
Other industries you might be interested in
Recent Healthcare Stocks Articles
Cannabis Stocks: Be Ready for the Next Catalyst
A new bill making its way through Congress is set to upend this outdated legal regime and usher in the next wave of growth in cannabis stocks.
Cannabis Stocks: We’ve Collected our First Cannabis Cash!
Matt McCall's strategy harnesses the growth of cannabis stocks and combines it with the income available from covered calls.
The Tables Could Soon Turn Back in Favor of Tilray Stock
Tilray stock has been beaten to a pulp, like most other pot stocks. But, there's a nuance here that could readily reignite TLRY shares.
VIDEO: Invest in Emerging Markets Stocks to Balance Your Portfolio
Invest in emerging markets stocks to balance your portfolio and position yourself for long-term growth. Tune into "Moneyline" for more.
Marijuana Stocks: How to Profit Twice
Use this proven strategy to boost your returns in an absolutely massive investing theme: marijuana legalization.
Aurora Cannabis Has Become a ‘Blood in the Streets’ Opportunity
Aurora Cannabis (ACB) stock has continously overpromised and underdelievered, but 'Cannabis 2.0' could be a major turning point for ACB stock holders.
Canopy Growth Emerges as Top ‘Cannabis 2.0’ Stock
Canopy Growth stock is down from its previous highs, but CGC stock is well-positioned for the next leg of cannabis trends.
3 Marijuana Stocks Better Than Aurora Cannabis
Popular marijuana stocks like Aurora have taken a beating in recent months as market enthusiasm has died down and reality has set in about growth and regulatory challenges. Today, the best cannabis plays may be under-the-radar stocks.
Will Cannabis 2.0 Save Canopy Growth Stock?
Will Cannabis 2.0 be enough to save CGC? The management of the company believes that it will be a major catalyst for CGC stock
It’s Finally Time to Consider Buying Canopy Growth Stock
After initially recommending investors stay on the sidelines with CGC, evidence is building that they should now consider purchasing shares.
Cronos Group Stock May Get Boost From Cannabinoid Production
Cronos may have an advantage in cannabinoid production, due to a strategic partnership. That could help CRON stock.
The Correction Is a Solid Opportunity to Buy Hexo Stock
Earlier in the year, you would've needed a good psychiatrist if you purchased HEXO stock at its lofty levels. But now? Hexo is ripe for the picking.
Cannabis Stocks: How to Earn a 100% Yield Next Year … No Joke
Thanks to a once-in-a-decade anomaly in the business world, there’s currently an investment offering 100%+ annual yields in the cannabis sector.
Aurora Cannabis Stock Holders Continue to Suffer Huge Goodwill Effects
Aurora Cannabis stock holders continue to suffer and this probably won't change anytime soon as the company faces numerous challenges.
Why You Should Wait to Buy Marijuana Stocks
I was recently asked if investors should buy marijuana stocks now or wait until we see profits. My answer? Wait. Here's why.
Canopy Growth Can Exonerate Vaping Industry
Investors may be tempted to dump CGC stock over Canopy’s vaping ambitions, but this could be an educational opportunity.
Akerna Earnings: KERN Stock Up 18% on 2019 Earnings
Akerna (KERN) earnings for the marijuana-tracking company's fiscal full year of 2019 has KERN stock soaring after hours Monday.
Battered Canopy Growth Stock Could Reach New Lows
CGC stock continues to face hurdles. With shares still overvalued, look elsewhere for pot stock opportunity.
3 Reasons Canopy Growth Stock Should Be a Long-Term Winner
CGC stock is poised to be a long-term winners thanks to deals with Constellation Brands and its acquisition of Acreage Holdings.
